Growth Metrics

Bioventus (BVS) Change in Receivables (2020 - 2026)

Bioventus filings provide 6 years of Change in Receivables readings, the most recent being -$1.9 million for Q4 2025.

  • On a quarterly basis, Change in Receivables fell 132.54% to -$1.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $916000.0, a 91.41% decrease, with the full-year FY2025 number at $916000.0, down 91.41% from a year prior.
  • Change in Receivables hit -$1.9 million in Q4 2025 for Bioventus, down from -$1.8 million in the prior quarter.
  • In the past five years, Change in Receivables ranged from a high of $25.6 million in Q3 2022 to a low of -$17.1 million in Q3 2024.
  • Median Change in Receivables over the past 5 years was $1.9 million (2023), compared with a mean of $2.0 million.
  • Biggest five-year swings in Change in Receivables: surged 989.74% in 2024 and later crashed 559.86% in 2025.
  • Bioventus' Change in Receivables stood at $6.9 million in 2021, then crashed by 30.0% to $4.8 million in 2022, then surged by 90.23% to $9.2 million in 2023, then crashed by 36.99% to $5.8 million in 2024, then crashed by 132.54% to -$1.9 million in 2025.
  • The last three reported values for Change in Receivables were -$1.9 million (Q4 2025), -$1.8 million (Q3 2025), and $13.6 million (Q2 2025) per Business Quant data.